NCT05652140

Brief Summary

The current research project aims to investigate the interaction of cardiorespiratory fitness (CRF) and the ApoE genotype with neurocognitive functions.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
159

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jul 2018

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2018

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2021

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

December 7, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 15, 2022

Completed
1.7 years until next milestone

Results Posted

Study results publicly available

August 19, 2024

Completed
Last Updated

November 15, 2024

Status Verified

November 1, 2024

Enrollment Period

2.8 years

First QC Date

December 7, 2022

Results QC Date

April 27, 2023

Last Update Submit

November 9, 2024

Conditions

Keywords

physical fitnessApolipoprotein Eevent-related potential

Outcome Measures

Primary Outcomes (2)

  • Changes in Inhibitory Performance: Stroop Task

    Inhibitory performance was assessed using the computerized Stroop task at the Baseline and at the Follow-Up assessments. The difference in response time (RT) between the Baseline and the Follow-Up Stages was calculated as the index of the inhibitory performance.

    30 minutes each at the Baseline and the Follow-Up visit at Month 18

  • Changes in Neuroelectrical Activities

    The neuroelectrical activities (P3 component) during the Stroop task were recorded and analyzed using the Neuroscan system. The difference in P3 amplitudes of incongruent trials between the Baseline and the Follow-Up Stages was calculated as the index of the neuroelectrical index.

    30 minutes each at the Baseline and the Follow-Up visit at Month 18

Secondary Outcomes (2)

  • Number of Participants for Whom ApoE Genotype Was Determined

    5 minutes at the Baseline Stage.

  • Physical Fitness Measurements: Changes in Aerobic Fitness

    30 minutes each at the Baseline and the Follow-Up visit at Month 18

Other Outcomes (1)

  • Changes in Higher Order Executive Performance: Tower of London Test

    30 minutes each at the Baseline and the Follow-Up Stages.

Study Arms (4)

High-Risk with increased CRF

ApoE e4 carriers with increased CRF from Baseline to the Follow-Up Stages.

Other: Data collections

High-Risk with decreased CRF

ApoE e4 carriers with decreased CRF from Baseline to the Follow-Up Stages.

Other: Data collections

Low-Risk with increased CRF

Non-ApoE e4 carriers with increased CRF from Baseline to the Follow-Up Stages.

Other: Data collections

Low-Risk with decreased CRF

Non-ApoE e4 carriers with decreased CRF from Baseline to the Follow-Up Stages.

Other: Data collections

Interventions

Data collections of cognitive function, neuroelectrical activities, ApoE genotype, and physical fitness.

High-Risk with decreased CRFHigh-Risk with increased CRFLow-Risk with decreased CRFLow-Risk with increased CRF

Eligibility Criteria

Age50 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Cognitively healthy late-middle-aged older adults recruited from the northern part of Taiwan.

You may qualify if:

  • right handed
  • no history of cardiorespiratory disease
  • normal or corrected-to-normal vision based on the 20/20 standard
  • no risk of performing physical activities, as measured by the Physical Activity Readiness Questionnaire

You may not qualify if:

  • the scores of Mini-Mental Status Examination (MMSE) \< 25 and cognitively intact upon study entry
  • history of psychiatric or neurological diseases
  • color-blindness

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Physical Education and Sport Sciences, National Taiwan Normal University

Taipei, 106308, Taiwan

Location

Limitations and Caveats

Due to the substantial overlapping of the study period with the COVID-19 pandemic, a larger-than-expected number of participants withdrew following the completion of the baseline stage.

Results Point of Contact

Title
Dr. Yu-Kai Chang
Organization
Department of Physical Education and Sport Sciences, National Taiwan Normal University

Study Officials

  • Yu-Kai Chang, Ph.D.

    Department of Physical Education and Sport Sciences, National Taiwan Normal University

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

December 7, 2022

First Posted

December 15, 2022

Study Start

July 1, 2018

Primary Completion

April 1, 2021

Study Completion

May 1, 2021

Last Updated

November 15, 2024

Results First Posted

August 19, 2024

Record last verified: 2024-11

Locations